Allstocks.com's Bulletin Board Post New Topic  Post A Reply
my profile login | register | search | faq | forum home

  next oldest topic   next newest topic
» Allstocks.com's Bulletin Board » .11 and Up! » NEXM moves big .. Look at that.. PR is on the way..

 - UBBFriend: Email this page to someone!    
Author Topic: NEXM moves big .. Look at that.. PR is on the way..
ChartWiz11
Member


Member Rated:
4
Icon 14 posted      Profile for ChartWiz11     Send New Private Message       Edit/Delete Post   Reply With Quote 
Up 100%..and moving towards %300

--------------------
Rely on Charts not luck.

Posts: 407 | From: NewYork, NY | Registered: Dec 2008  |  IP: Logged | Report this post to a Moderator
ChartWiz11
Member


Member Rated:
4
Icon 1 posted      Profile for ChartWiz11     Send New Private Message       Edit/Delete Post   Reply With Quote 
My target is above 0.25. There is only 80+ million shares outstanding.. Very above average volume.

--------------------
Rely on Charts not luck.

Posts: 407 | From: NewYork, NY | Registered: Dec 2008  |  IP: Logged | Report this post to a Moderator
ChartWiz11
Member


Member Rated:
4
Icon 1 posted      Profile for ChartWiz11     Send New Private Message       Edit/Delete Post   Reply With Quote 
with Astra Zeneca potential 300 Million dollars and has a 6 million dollar market cap FULLY funded for 2009 from last news on deal PTN

"The license extension and clinical trial agreements point to the progress Palatin and AstraZeneca have made with their collaborative melanocortin receptor obesity program," stated Stephen T. Wills, Palatin's EVP of Operations and CFO. "Of the total $6.6 million due from AstraZeneca, we anticipate receiving $4.1 million by December 31, 2008 and the remaining $2.5 million in the first quarter of calendar year 2009. This $6.6 million, coupled with $1.7 million that Palatin received this month from the sale of net operating losses to the State of New Jersey, $700,000 from the sale of non-core fixed assets, and a cash and cash equivalents balance of $8.1 million at September 30, 2008, gives Palatin sufficient cash to fund its projected operations through calendar year 2009."

Under terms of the original collaboration and license agreement signed in January 2007, Palatin received an upfront payment of $10 million from AstraZeneca and is eligible for milestone payments totalling $300 million, with up to $180 million contingent upon development and regulatory milestones and the balance on achievement of sales targets, together with the payment of stepped royalties on product sales to double digit rates, dependent on sales achieved. AstraZeneca is responsible for product commercialization, product discovery and development costs.

--------------------
Rely on Charts not luck.

Posts: 407 | From: NewYork, NY | Registered: Dec 2008  |  IP: Logged | Report this post to a Moderator
ChartWiz11
Member


Member Rated:
4
Icon 1 posted      Profile for ChartWiz11     Send New Private Message       Edit/Delete Post   Reply With Quote 
0.13

Big Gap coming tomorrow

--------------------
Rely on Charts not luck.

Posts: 407 | From: NewYork, NY | Registered: Dec 2008  |  IP: Logged | Report this post to a Moderator
ChartWiz11
Member


Member Rated:
4
Icon 1 posted      Profile for ChartWiz11     Send New Private Message       Edit/Delete Post   Reply With Quote 
Pre-Market opened 0.25.. Currently 0.22

--------------------
Rely on Charts not luck.

Posts: 407 | From: NewYork, NY | Registered: Dec 2008  |  IP: Logged | Report this post to a Moderator
   

Quick Reply
Message:

HTML is enabled.
UBB Code™ is enabled.

Instant Graemlins
   


Post New Topic  Post A Reply Close Topic   Feature Topic   Move Topic   Delete Topic next oldest topic   next newest topic
 - Printer-friendly view of this topic
Hop To:


Contact Us | Allstocks.com Message Board Home

© 1997 - 2021 Allstocks.com. All rights reserved.

Powered by Infopop Corporation
UBB.classic™ 6.7.2

Share